BioCentury
ARTICLE | Product R&D

Debugging the microbiome

How BiomX is using bacteriophages to modulate the microbiome

February 9, 2018 12:51 AM UTC

BiomX Ltd. is moving phage therapies beyond infectious disease and into chronic conditions driven by the microbiome. The Israeli biotech has pieced together a suite of tools that can identify bad actors within microbial communities and design cocktails of phages to selectively target them.

Bacteriophages, or phages, are viruses that infect and kill bacteria. They are highly selective for individual bacterial species or sometimes strains, and attack the bugs by different mechanisms from antibiotics. ...